Cargando…

Metabolic abnormalities and survival among patients with non-metastatic breast cancer

BACKGROUND: Research on the impact of metabolic abnormalities on breast cancer prognosis is limited by small samples and assessment of laboratory values at a single time point, often prior to cancer diagnosis and treatment. In this population-based cohort, time-updated laboratory values were adjuste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimbalist, Alexa S., Caan, Bette J., Chen, Wendy Y., Mittendorf, Elizabeth A., Dillon, Deborah A. R., Quesenberry, Charles, Cespedes Feliciano, Elizabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801571/ https://www.ncbi.nlm.nih.gov/pubmed/36581817 http://dx.doi.org/10.1186/s12885-022-10430-9

Ejemplares similares

ADIPOSE TISSUE DISTRIBUTION AND SURVIVAL AMONG WOMEN WITH NON-METASTATIC BREAST CANCER
por: Bradshaw, Patrick T., et al.
Publicado: (2019)

The evolution of body composition in oncology—epidemiology, clinical trials, and the future of patient care: facts and numbers
por: Brown, Justin C., et al.
Publicado: (2019)

Abdominal adipose tissue radiodensity is associated with survival after colorectal cancer
por: Feliciano, Elizabeth M Cespedes, et al.
Publicado: (2021)

Screening for low muscularity in colorectal cancer patients: a valid, clinic‐friendly approach that predicts mortality
por: Cespedes Feliciano, Elizabeth M., et al.
Publicado: (2018)

Body composition from single versus multi‐slice abdominal computed tomography: Concordance and associations with colorectal cancer survival
por: Anyene, Ijeamaka, et al.
Publicado: (2022)

Associations of pre‐existing co‐morbidities with skeletal muscle mass and radiodensity in patients with non‐metastatic colorectal cancer
por: Xiao, Jingjie, et al.
Publicado: (2018)

The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I–III colorectal cancer: a population‐based cohort study (C‐SCANS)
por: Brown, Justin C., et al.
Publicado: (2018)

Changing population characteristics, effect-measure modification, and cancer risk factor identification
por: Slattery, Martha L, et al.
Publicado: (2007)

Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women’s Health Initiative
por: Cespedes Feliciano, Elizabeth M., et al.
Publicado: (2020)

Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients
por: Cespedes Feliciano, Elizabeth M., et al.
Publicado: (2020)

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial
por: Ibrahim, Nuhad K., et al.
Publicado: (2013)

Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study
por: Anyene, Ijeamaka C., et al.
Publicado: (2021)

Prostatitis, Sexually Transmitted Diseases, and Prostate Cancer: The California Men's Health Study
por: Cheng, Iona, et al.
Publicado: (2010)

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression
por: Kwan, Marilyn L, et al.
Publicado: (2015)

Diet Quality and Breast Cancer Recurrence and Survival: The Pathways Study
por: Ergas, Isaac J, et al.
Publicado: (2021)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2021)

Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers
por: Cheng, En, et al.
Publicado: (2021)

California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting
por: Enger, Shelley M, et al.
Publicado: (2006)

Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival
por: Sharafeldin, Noha, et al.
Publicado: (2017)

Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008
por: Gordon, Nancy P, et al.
Publicado: (2012)

Scaling of computed tomography body composition to height: relevance of height‐normalized indices in patients with colorectal cancer
por: Brown, Justin C., et al.
Publicado: (2021)

Mapping conflict of interests: scoping review
por: Chimonas, Susan, et al.
Publicado: (2021)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
por: Kwan, Marilyn L, et al.
Publicado: (2009)

Effect of Exercise on Sarcopenia among Cancer Survivors: A Systematic Review
por: Cao, Anlan, et al.
Publicado: (2022)

Adipose tissue n-3 fatty acids and metabolic syndrome
por: Cespedes, Elizabeth, et al.
Publicado: (2014)

Pre-Diagnosis Exercise and Cardiovascular Events in Primary Breast Cancer: Women’s Health Initiative
por: Okwuosa, Tochi M., et al.
Publicado: (2019)

A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes’ Effects on Moms (GEM) study
por: Ferrara, Assiamira, et al.
Publicado: (2014)

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
por: Waks, Adrienne G, et al.
Publicado: (2022)

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer
por: Kantor, Olga, et al.
Publicado: (2020)

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
por: Gallagher, Christopher M., et al.
Publicado: (2016)

HUNK Signaling in Metastatic Breast Cancer
por: Dilday, Tinslee, et al.
Publicado: (2020)

Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?
por: Mittendorf, Elizabeth A., et al.
Publicado: (2009)

Patterns of Care and Survival of Metastatic Metaplastic Breast Cancer Patients
por: Youssef, Irini, et al.
Publicado: (2020)

Defining the illness trajectory of metastatic breast cancer
por: Reed, Elizabeth, et al.
Publicado: (2015)

Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer
por: Minami, Christina A., et al.
Publicado: (2020)

Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors
por: Reding, Kerryn W., et al.
Publicado: (2022)

Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer
por: Liu, P, et al.
Publicado: (2013)

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients
por: Abdelaziz, Lobna A., et al.
Publicado: (2022)

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
por: Hurvitz, Sara A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gol0hb0tuo5ieod1798kh5sah3